Creoptix focuses on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research. Creoptix was acquired by Malvern Panalytical in 2022.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2009
  • Number of employees in Switzerland
    10-19

You May Also Be Interested In